Lv2
160 积分 2022-08-09 加入
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma
2个月前
已完结
Therapeutic potential of cis-targeting bispecific antibodies
4个月前
已完结
Prediction of Human Pharmacokinetics and Clinical Effective Dose of SI–B001, an EGFR/HER3 Bi-specific Monoclonal Antibody
10个月前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
1年前
已完结
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML
1年前
已完结
What makes a good antibody-drug conjugate?
1年前
已完结
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma
1年前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
1年前
已完结
The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development
1年前
已完结
Masking T cell engagers mitigates on-target off-tumor activity
1年前
已完结
皖公网安备34019202002308
